Seelos Therapeutics (SEEL) Stock Forecast & Price Target
Seelos Therapeutics, Inc. analyst ratings
| Rating | Analysts |
|---|---|
| Strong buy | 0 |
| Buy | 6 |
| Hold | 2 |
| Sell | 0 |
| Strong sell | 0 |
| Consensus | Buy |
8 analysts cover SEEL.
Is Seelos Therapeutics, Inc. a buy or sell?
Of the 8 analysts covering Seelos Therapeutics, Inc., 6 rate it a buy (0 strong buy and 6 buy), 2 rate it a hold, and 0 rate it a sell (0 sell and 0 strong sell).
The SEEL consensus label is Buy, beside 6 buy-side ratings and 0 sell-side ratings.
Those 8 ratings on SEEL are a headcount, and the label on file is Buy.
Reading the Seelos Therapeutics, Inc. forecast
Ratings on the Seelos Therapeutics, Inc. cluster: 6 of 8 analysts are on the buy side, 2 are at hold, and 0 are on the sell side, and the published consensus is Buy.
Only 8 analysts cover SEEL, so the average rests on a short list.
Seelos Therapeutics, Inc. forecast questions
What is the SEEL price target?
No average price target is on file for SEEL.
Is Seelos Therapeutics, Inc. a buy or sell?
Of the 8 analysts covering Seelos Therapeutics, Inc., 6 rate it a buy, 2 rate it a hold, and 0 rate it a sell. The consensus is Buy, and the SEEL headcount is 6 buy, 2 hold, and 0 sell.
What is the EPS estimate for Seelos Therapeutics, Inc.?
No EPS estimate for the next two fiscal years is on file for Seelos Therapeutics, Inc..
What is the revenue estimate for Seelos Therapeutics, Inc.?
No revenue estimate for the next two fiscal years is on file for Seelos Therapeutics, Inc..
How many analysts cover SEEL?
8 analysts cover SEEL. Their consensus on SEEL is Buy, across those 8.